Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Dermatol ; 179(4): 951-958, 2018 10.
Article in English | MEDLINE | ID: mdl-29729180

ABSTRACT

BACKGROUND: Carriage rates of Staphylococcus aureus on affected skin in atopic dermatitis (AD) are approximately 70%. Increasing disease severity during flares and overall disease severity correlate with increased burden of S. aureus. Treatment in AD therefore often targets S. aureus with topical and systemic antimicrobials. OBJECTIVES: To determine whether antimicrobial sensitivities and genetic determinants of resistance differed in S. aureus isolates from the skin of children with AD and healthy child nasal carriers. METHODS: In this case-control study, we compared S. aureus isolates from children with AD (n = 50) attending a hospital dermatology department against nasal carriage isolates from children without skin disease (n = 49) attending a hospital emergency department for noninfective conditions. Using whole genome sequencing we generated a phylogenetic framework for the isolates based on variation in the core genome, then compared antimicrobial resistance phenotypes and genotypes between disease groups. RESULTS: Staphylococcus aureus from cases and controls had on average similar numbers of phenotypic resistances per isolate. Case isolates differed in their resistance patterns, with fusidic acid resistance (FusR ) being significantly more frequent in AD (P = 0·009). The genetic basis of FusR also differentiated the populations, with chromosomal mutations in fusA predominating in AD (P = 0·049). Analysis revealed that FusR evolved multiple times and via multiple mechanism in the population. Carriage of plasmid-derived qac genes, which have been associated with reduced susceptibility to antiseptics, was eight times more frequent in AD (P = 0·016). CONCLUSIONS: The results suggest that strong selective pressure drives the emergence and maintenance of specific resistances in AD.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Dermatitis, Atopic/microbiology , Drug Resistance, Bacterial/drug effects , Staphylococcal Skin Infections/microbiology , Staphylococcus aureus/physiology , Administration, Cutaneous , Anti-Infective Agents, Local/administration & dosage , Carrier State/diagnosis , Carrier State/drug therapy , Carrier State/microbiology , Case-Control Studies , Child , Child, Preschool , Dermatitis, Atopic/diagnosis , Dermatitis, Atopic/drug therapy , Drug Resistance, Bacterial/genetics , Female , Healthy Volunteers , Humans , Infant , Infant, Newborn , Male , Microbial Sensitivity Tests , Mutation , Nasal Mucosa/microbiology , Peptide Elongation Factor G/genetics , Peptide Elongation Factor G/isolation & purification , Severity of Illness Index , Skin/microbiology , Staphylococcal Skin Infections/diagnosis , Staphylococcal Skin Infections/drug therapy , Staphylococcus aureus/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...